AzTrials
AzTrials

SchizophreniaIPS_FIRAHNCT04436757

Self and Body-esteem in Socio-professional Rehabilitation

A study testing IPS program : Self-image and body representation and TAU in people with Schizophrenia and Bipolar Disorder, run by Hôpital le Vinatier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The body esteem influences the physical appearance, which can be a social brake. To enhance the socio-professional insertion of persons with severe mental disorders, the investigators developed a group program about self-presentation and body esteem. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
IPS program : Self-image and body representation and TAU
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteFrance
Study dates
22 Jun 2020to 17 Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 to 65.
  • Speaking French.
  • Diagnosis of severe mental disorders (MSD) established according to the criteria of the DSM-V (Diagnostic and Statistical Manual of Mental Disorders) such as: Schizophrenia, Bipolar Disorders, Serious Personality Disorders, Severe Anxiety Disorders, Depressive Disorders; with a clinical stability of more than 3 months.
  • Supported at SUR/CL3R with an application for socio-professional reintegration.
  • Guardian agreement (for persons under guardianship);
  • Information given to the curator (for persons under curatorship);
  • Member of the social security scheme.

Who cannot join

  • Diagnosis of Autism Spectrum Disorder (ASD) or Eating Behaviour Disorder.
  • Clinical status incompatible with group activity.
  • Acute episode in progress.
  • Refusal to participate.
  • Simultaneous participation in a psycho-social rehabilitation program targeting image or self-esteem (general and/or body).

Trial locations and contacts

1 site in 1 country.

France1 site
  • centre de réhabilitation - Hôpital le Vinatier

    Lyon, Rhône, 69006

Other trials in France

About this study

Official title: Group Program IPS: Body-esteem and Self-esteem in a Psycho-social Rehabilitation Perspective

The body esteem influences the physical appearance, which can be a social brake. To enhance the socio-professional insertion of persons with severe mental disorders, the investigators developed a group program about self-presentation and body esteem. The study's objective is to understand the body esteem impact on socio-professional insertion, and how to improve that with a dedicated group program, for patients in a psychosocial rehabilitation center

Read the detailed description

Our hypothesis is that a group program centered on the image and the presentation of the self, with the intervention of professionals of the image of the body, such as socio-hairdresser, socio-beautician, allows a better socio-professional inclusion, through an improvement in body self-esteem. Taking care of yourself will require different approaches such as advice on hygiene, becoming aware of your body, experimenting with beauty treatments and having the means to reproduce them at home. We will compare our IPS program (Image and Presentation of Self), with the usual management in the care center (TAU = "Treatment As Usual")

Being tested
IPS program : Self-image and body representation, TAU
Keywords
severe mental disorders, body-esteem, body-representation, self-esteem, socio-professional insertion
Medical subject headings
Schizophrenia, Bipolar Disorder, Personality Disorders, Anxiety Disorders, Depressive Disorder, Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IPS program : Self-image and body representationBehavioural

    The IPS program consists in 13 sessions of 2 hours over a 13-weeks period.

    Sessions content is as follows :

    1. : Introduction
    2. : Sensory approach workshop
    3. : Self presentation and personal hygiene
    4. : Organisation of well-being, planning and pictograms
    5. : Becoming aware of my body, my envelope
    6. : Presentation and self-esteem (photolanguage)
    7. : Self-presentation in social interactions: Social codes
    8. : My ideas and desires for change
    9. : Places of well-being and clothing hygiene
    10. : Vocational insertion devices
    11. : Daring change : presence of a Socio-hairdresser
    12. : The awakening of color : presence of a Socio-aesthetician
    13. : Development of practice sheets and the network
  • TAUBehavioural

    The treatment of the group TAU (Treatment As Usual) will consist of the usual care proposed by the health service. No additional session will be proposed.

Study groups in NCT04436757
Study groupRoleWhat they receive
IPS (Self-image and body-representation program)ExperimentalThe IPS program (Self-image and body representation) was designed by Dr PLAZAT and coll. for specific use with patients with severe mental disorders suffering of low self- and body-esteem and aiming at " reinsert themselves" in the society.
Receives: Behavioral: IPS program : Self-image and body representation
TAUActive comparatorTreatment As Usual : the usual care proposed by the health service (SUR/CL3R).
Receives: Behavioral: TAU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Appreciation of one's own appearance

    The main judgement criterion is the difference before/after the program for each of the two groups (IPS and TAU) of the weighted average at the "satisfaction with overall appearance" and "wish to change appearance" dimensions of the BES (Body-Esteem Scale), common dimensions for men and women. This difference will be compared between the 2 groups by a Student test (or a Wilcoxon-Mann-Whitney test in case of non normality).

    Measured: baseline, one month, three months, nine months after the end of the treatment

Secondary outcomes (4)
  1. Appreciation of the Self-esteem measured by the Self-Esteem Rating Scale

    As for the primary outcome

    Measured: baseline, one month, three months, nine months after the end of the treatment

  2. Appreciation of the well-being measured by the Warwick-Edinburgh Well-Being Mental Scale

    As for the primary outcome

    Measured: baseline, one month, three months, nine months after the end of the treatment

  3. Appreciation of the satisfaction level measured by the Client's Assessment of Strengths, Interests and Goals Scale (CASIG )

    As for the primary outcome

    Measured: baseline, one month, three months, nine months after the end of the treatment

  4. Appreciation of the satisfaction measured by the Satisfaction in the domains of life

    As for the primary outcome

    Measured: baseline, one month, three months, nine months after the end of the treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2020
  2. Study start22 Jun 2020
  3. Primary completion17 Oct 2023
  4. Study completion17 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized, single-centre, comparative, interventional study, treated in open parallel groups, measuring the impact of "professional" body image intervention on improving body self-esteem in patients with severe mental health problems.
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04436757
Sponsor's protocol ID
2020-A00777-32
Acronym
IPS_FIRAH
Status last verified
Jul 2025
First submitted
16 Jun 2020
Last updated
31 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing IPS program : Self-image and body representation and TAU in people with Schizophrenia and Bipolar Disorder, run by Hôpital le Vinatier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Appreciation of one's own appearance (time frame: baseline, one month, three months, nine months after the end of the treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in